JapanBridge Adds $6.5 Million

JapanBridge Inc., a Tokyo-based drug company, has raised $6.5 million in Series A-2 funding. Return backers MPM Capital and Itochu were joined by new strategic partner Kyowa Hakko Kogyo Co. Ltd., which will collaborate with JapanBridge on the commercialization of oncology and oncology supportive care assets in Japan. www.japanbridge.co.jp